Free Light Chains (Kappa & Lambda), Serum near me in New Delhi
Understanding Free Light Chains (Kappa & Lambda), Serum in New Delhi
What is Free Light Chains (Kappa & Lambda), Serum in New Delhi?
The Free Light Chains (Kappa & Lambda), Serum test is a blood test that evaluates the level of two types of protein called light chains: Kappa and lambda, helping in the early detection and monitoring of multiple myeloma (a blood cancer) and other disorders related to plasma cells. This test also provides complementary information by determining the ratio of Kappa and lambda (Kappa:Lambda) providing more in-depth information about the type, severity, and progression of these plasma cell disorders. This test is available at an affordable price in New Delhi. Usually, no special preparation is required for the Free Light Chains (Kappa & Lambda), Serum test. You may eat and drink as per your daily routine.
What does Free Light Chains (Kappa & Lambda), Serum measure?
Contains 3 testsThe Free Light Chains (Kappa & Lambda), Serum test measures the free (unbound) kappa and lambda light chains in the blood. Light chains are small proteins produced by plasma cells, a type of white blood cell. They can combine with other proteins (heavy chains) to form immunoglobulins, or antibodies, which help fight infections. When light chains are produced in excess, they do not combine with heavy chains and instead enter the blood in a "free" state, unbound to heavy chains.
This test also determines the balance or ratio of kappa to lambda light chains in the blood (kappa: lambda ratio) which can provide valuable information about disorders related to plasma cells, such as multiple myeloma, a type of bone marrow cancer. It is also useful in monitoring treatment response and disease progression in these conditions.
Kappa/Lambda Ratio
The Kappa/Lambda Ratio test measures the balance of two types of free light chains: free kappa light chains and free lambda light chains. These light chains are components of antibodies produced by plasma cells as part of the immune response. Normally, a small amount of free light chains are present in the bloodstream, but in some conditions, such as plasma cell disorders like primary amyloidosis, multiple myeloma, Waldenström macroglobulinemia, and monoclonal gammopathies, the production of these light chains can rise significantly.
By considering the balance between kappa and lambda light chains, rather than just their individual levels, the Kappa/Lambda Ratio test provides a more comprehensive assessment of light chain production and its relevance to diagnosing plasma cell proliferation.
Know more about Kappa/Lambda Ratio
Kappa Light Chains
The Kappa Light Chains test measures the free (unbound) kappa light chains in the blood. Light chains are small proteins produced by plasma cells, a type of white blood cell. They can combine with other proteins (heavy chains) to form immunoglobulins, or antibodies, which help fight infections. When kappa light chains are produced in excess, they do not combine with heavy chains and instead enter the blood in a "free" state, unbound to heavy chains. Abnormal levels of kappa free light chains can indicate various diseases, including multiple myeloma and other plasma cell disorders. Thus, measuring the Kappa light chains levels plays a crucial role in the comprehensive evaluation and management of blood-related disorders, ultimately benefiting individuals by enabling timely diagnosis, personalized treatment approaches, and improved clinical outcomes.
Know more about Kappa Light Chains
Lambda Light Chains
The Lambda Light Chains test measures the free (unbound) lambda light chains in the blood. Light chains are small proteins produced by plasma cells, a type of white blood cell. They are part of antibodies, which are used by the immune system to identify and neutralize foreign objects. Normally, light chains combine with heavy chains to form antibodies. However, some light chains are not bound to heavy chains and are therefore termed as “free” light chains.
Abnormal levels of lambda-free light chains can indicate various diseases, including multiple myeloma and other plasma cell disorders. Thus, quantifying the lambda light chains levels plays a crucial role in the comprehensive evaluation and management of blood-related disorders, ultimately benefiting individuals by enabling timely diagnosis, personalized treatment approaches, and improved clinical outcomes.
Know more about Lambda Light Chains